CVI Holdings
PLXP

CVI Holdings’s PLx Pharma Inc. Common Stock PLXP Stock Holding History

CVI Holdings’s Portfolio PLXP Stock Details PLXP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-13,878
Closed -$56K – 52
2018
Q3 		$56K Sell
13,878
-15,404
-53% -$57.9K 0.09% 30
2018
Q2 		$116K Sell
29,282
-16,814
-36% -$68.7K 0.14% 31
2018
Q1 		$154K Buy
+46,096
New +$292K 0.21% 29

Other funds holding PLXP

Park West Asset Management
Park West Asset Management San Francisco, California $1.47B AUM 86.42% 1-Year Est. Return
Harel Insurance Investments & Financial Services
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
University of Texas/Texas AM Investment Management Co (UTIMCO)
University of Texas/Texas AM Investment Management Co (UTIMCO) Austin, Texas $863M AUM 30.35% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Fayez Sarofim & Co
Fayez Sarofim & Co Houston, Texas $42.5B AUM 18.19% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

CVI Holdings's PLXP Position: Q4 2018 in Review

CVI Holdings sold out of PLx Pharma Inc. Common Stock (PLXP) in Q4 2018, closing a stake of 13,878 shares — an estimated $56K sold.

CVI Holdings first reported a position in PLXP in Q1 2018 and held it in 3 quarters. The position peaked at $154K in Q1 2018. 14 funds tracked by Wall St. Rank hold PLXP as of Q4 2018.

  • CVI Holdings reported no remaining PLx Pharma Inc. Common Stock position as of Q4 2018 after selling out during the quarter.
  • CVI Holdings sold 13,878 PLx Pharma Inc. Common Stock shares in Q4 2018, an estimated $56K.
  • CVI Holdings first reported a position in PLx Pharma Inc. Common Stock in Q1 2018 and held it in 3 quarters.
  • CVI Holdings's PLx Pharma Inc. Common Stock position peaked at $154K in Q1 2018.
  • 14 funds tracked by Wall St. Rank held PLx Pharma Inc. Common Stock as of Q4 2018.

Based on CVI Holdings's 13F filing for Q4 2018, filed 14 Feb 2019.